These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2304356)

  • 1. Bone marrow cultures and prognosis in primary myelodysplastic syndromes.
    Korthout M; De Bock R; van Bockstaele D; Peetermans M
    Leuk Res; 1990; 14(1):85-9. PubMed ID: 2304356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous colony forming ability in vitro of the abnormal clone-derived granulocyte-macrophage precursors in myelodysplastic syndromes.
    Okuda T; Yokota S; Maekawa T; Sonoda Y; Misawa S; Takino T; Abe T
    Leuk Res; 1988; 12(8):687-92. PubMed ID: 3184986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
    Tennant GB; Jacobs A; Bailey-Wood R
    Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.
    Dan K; An E; Futaki M; Inokuchi K; Gomi S; Yamada T; Ogata K; Tanabe Y; Ohki I; Shinohara T
    Acta Haematol; 1993; 89(3):113-8. PubMed ID: 8362599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score.
    Oscier DG; Worsley A; Darlow S; Figes A; Williams JD; Hamblin TJ
    Leuk Res; 1989; 13(9):833-9. PubMed ID: 2796388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow in vitro growth and cytogenetic studies in patients with FAB-classified primary myelodysplastic syndromes.
    Swolin B; Rödjer S; Westin J
    Am J Hematol; 1990 Jul; 34(3):175-80. PubMed ID: 2363412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined effects of Il-3, GM-CSF and G-CSF on the in vitro growth of myelodysplastic myeloid progenitor cells.
    Schipperus MR; Sonneveld P; Lindemans J; Vink N; Vlastuin M; Hagemeijer A; Abels J
    Leuk Res; 1990; 14(11-12):1019-25. PubMed ID: 1704083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes.
    Geissler K; Hinterberger W; Jäger U; Bettelheim P; Neumann E; Haas O; Ambros P; Chott A; Radaszkiewicz T; Lechner K
    Blut; 1988 Jul; 57(1):45-9. PubMed ID: 3390617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Culture of cells forming granulomonocytic colonies in bone marrow (GM-CFU) in myelodysplastic syndromes and their relation to hematological findings and FAB subtype].
    García M; Sanz GF; Arriaga F; Pérez-Sirvent ML; Marty ML; Sanz MA
    Sangre (Barc); 1991 Aug; 36(4):269-75. PubMed ID: 1776105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal growth of haemopoietic progenitor cells from myelodysplastic marrow in response to recombinant haemopoietins.
    Baines P; Bowen D; Jacobs A
    Leuk Res; 1990; 14(3):247-53. PubMed ID: 1690828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
    Backx B; Broeders L; Touw I; Löwenberg B
    Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro growth modulation by L-ascorbic acid of colony-forming cells from bone marrow of patients with myelodysplastic syndromes.
    Park CH; Kimler BF; Bodensteiner D; Lynch SR; Hassanein RS
    Cancer Res; 1992 Aug; 52(16):4458-66. PubMed ID: 1643638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In-vitro change in CFU-GM in chronic myeloid leukemia and myelodysplastic syndromes. Its implication in the dysfunction of the hematologic barrier].
    Gronda M; Malka A; Demattei A; Elizalde P; Santarelli MT; Bianchi de Di Risio CC
    Sangre (Barc); 1988 Aug; 33(4):277-81. PubMed ID: 3187844
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation by retinoic acid of the growth of bone marrow cell progenitors from patients with myelodysplastic syndrome.
    De Francesco A; Sanavio F; Stacchini A; Piacibello W; Quaglino D; Aglietta M
    Haematologica; 1989; 74(1):25-8. PubMed ID: 2498179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of bone marrow culturing in myelodysplastic syndrome: a retrospective analysis.
    Raymakers R; Preijers F; Boezeman J; Rutten E; De Witte T
    Leuk Lymphoma; 1994 Jun; 14(1-2):111-20. PubMed ID: 7920217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of an in vitro method of granulomonocytic colonies for the diagnosis and prognosis of myelodysplastic syndromes].
    Grigoriu G; Puşcariu T; Ursea C; Munteanu N; Butoianu E; Coliţă A; Popp A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(1):61-8. PubMed ID: 2899349
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic implication of sequential bone marrow cultures in the myelodysplastic syndromes.
    Yoshida Y; Yoshida C; Tohyama K; Ohmori S; Ohmori M; Ueda Y; Taniguchi Y; Uchino H
    Leuk Res; 1989; 13(11):967-72. PubMed ID: 2607778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a calf thymus acid lysate on bone marrow cell growth in vitro.
    Vasilopoulos G; Porwit A; Lauren L; Reizenstein P; Cazzola P
    Immunopharmacol Immunotoxicol; 1988; 10(4):523-36. PubMed ID: 3266754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
    Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
    Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.